Table 1. Patient characteristics.
| Variables | Patient number or median [range] |
|---|---|
| Recipient gender | |
| Male | 6 |
| Female | 9 |
| Recipient age (years) | 58 [36–74] |
| Donor gender | |
| Male | 9 |
| Female | 6 |
| Donor age (years) | 40 [29–64] |
| Graft type | |
| Left | 5 |
| Right | 10 |
| Background liver disease | |
| Viral | 7 |
| Others | 8 |
| MELD score | 17 [7–23] |
| CTP score | 11 [10–13] |
| Graft volume/standard liver volume (%) | 43.7 [31.2–67.1] |
| Graft recipient weight ratio (%) | 0.79 [0.65–1.19] |
| Simultaneous splenectomy at transplant | |
| Yes | 12 |
| No | 3 |
| Intraoperative blood loss (mL) | 4,490 [875–18,450] |
| Operation time (min) | 708 [509–978] |
| Portal pressure at the end of the operation (mmHg) | 16 [13–21] |
| Portal venous flow per gram of graft (mL/min/g) | 2.97 [1.53–7.42] |
| Pretransplant M2BPGi (C.O.I.) | 9.75 [3.04–24.49] |
| POD 1 M2BPGi (C.O.I.) | 1.48 [0.9–7.63] |
| POD 3 M2BPGi (C.O.I.) | 1.47 [0.47–2.93] |
| POD 7 M2BPGi (C.O.I.) | 1.49 [0.46–4.74] |
C.O.I., cutoff index; CTP, Child-Turcotte-Pugh; M2BPGi, Wisteria floribunda agglutinin positive human Mac-2 binding protein glycosylation isomer; MELD, Model for End-Stage Liver Disease; POD, postoperative days; SFSS, small-for-size syndrome